Dr Reddys Laboratories (RDY) Accounts Payables: 2018-2025

Historic Accounts Payables for Dr Reddys Laboratories (RDY) over the last 8 years, with Mar 2025 value amounting to $417.0 million.

  • Dr Reddys Laboratories' Accounts Payables rose 12.40% to $417.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $417.0 million, marking a year-over-year increase of 12.40%. This contributed to the annual value of $417.0 million for FY2025, which is 12.40% up from last year.
  • Per Dr Reddys Laboratories' latest filing, its Accounts Payables stood at $417.0 million for FY2025, which was up 12.40% from $371.0 million recorded in FY2024.
  • Over the past 5 years, Dr Reddys Laboratories' Accounts Payables peaked at $417.0 million during FY2025, and registered a low of $322.0 million during FY2023.
  • Over the past 3 years, Dr Reddys Laboratories' median Accounts Payables value was $371.0 million (recorded in 2024), while the average stood at $370.0 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first surged by 47.06% in 2021, then dropped by 4.45% in 2023.
  • MRY analysis of 5 years shows Dr Reddys Laboratories' Accounts Payables stood at $325.0 million in 2021, then grew by 3.69% to $337.0 million in 2022, then dropped by 4.45% to $322.0 million in 2023, then rose by 15.22% to $371.0 million in 2024, then rose by 12.40% to $417.0 million in 2025.
  • Its Accounts Payables was $417.0 million in FY2025, compared to $371.0 million in FY2024 and $322.0 million in FY2023.